Tweet
clear
INSIDER™
Invest
Research
News
Watch
Discuss
Learn
WealthLift Stock Research
Find the Best Stocks to Invest in with the WealthLift Stock Research
clear
No Stock was found with the given ticker. Please search again.
+ Follow
( )
Rate Stock
Sentiment:
100.00
/100
Last Price:
Change:
0.00%
Key Indicators
Prev. Close
Day Range
-
52wk Range
-
Volume
0
Avg Vol.
0
Shares Outs.
0
Market Cap
0
P/E
N/A
EPS
Dividend/Yield
None / 0.00%
Stock Wall -
Latest News -
To comment on the stock wall, sign up for free in less than 30 seconds
Halozyme Firing On All Cylinders - Should Investors Get Behind The Wheel?
Halozyme Therapeutics Breaks Below 200-Day Moving Average - Notable for HALO
Spectrum Pharma names Gustafson as new CFO
Spectrum Pharma names Gustafson as new CFO
Halozyme's Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
3 Stocks to Watch Ahead of ASCO
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Ahead Of The Trend: 7 Rallying Stocks With Institutional Selling And Short Increases
CFO Moves: KeyCorp, Huntington Bancshares, Halozyme
Halozyme names David Ramsay as CFO
Halozyme names David Ramsay as CFO
The Coming Diabetes Wars
Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
American Society Of Clinical Oncology Abstracts Point To Potential Profits
Baxter Receives Marketing Authorization for HyQvia in European Union
3 Humongous Health-Care Stocks This Week
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
Cancer Drug Drama Rocks 2 Biotech Stocks
Halozyme rises on pancreatic cancer drug study
Halozyme rises on prostate cancer drug study
1 new update
